Safety and biodegradability of a synthetic dural sealant patch(Liqoseal)in a porcine cranial model
Safety and biodegradability of a synthetic dural sealant patch(Liqoseal) in a porcine cranial model作者机构:Department of Neurology and NeurosurgeryBrain CenterUniversity Medical Centre UtrechtUtrechtThe Netherlands Brain Technology InstituteUtrechtThe Netherlands Division of PathologyFaculty of Veterinary MedicineUtrecht UniversityUtrechtThe Netherlands Department of NeurosurgeryClinical Neuroscience CenterUniversity Hospital ZurichZurichSwitzerland
出 版 物:《Animal Models and Experimental Medicine》 (动物模型与实验医学(英文))
年 卷 期:2021年第4卷第4期
页 面:398-405页
核心收录:
学科分类:0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 10[医学]
基 金:Polyganics BV funded all experiments。
主 题:cerebrospinal fluid leakage craniotomy dura in vivo model sealant
摘 要:Background:Liqoseal consists of a watertight layer of poly(ester)ether urethane and an adhesive layer containing polyethylene glycol-N-hydroxysuccinimide(PEG-NHS).It is designed to prevent cerebrospinal fluid(CSF)leakage after intradural surgery.This study assessed the safety and biodegradability of Liqoseal in a porcine craniotomy model.Methods:In 32 pigs a craniotomy plus durotomy was performed.In 15 pigs Liqoseal was implanted,in 11 control pigs no sealant was implanted and in 6 control pigs a control dural sealant(Duraseal or Tachosil)was implanted.The safety of Liqoseal was evaluated by clinical,MRI and histological assessment.The degradation of Liqoseal was histologically estimated.Results:Liqoseal,2 mm thick before application,did not swell and significantly was at maximum mean thickness of 2.14(±0.37)mm at one month.The foreign body reaction induced by Liqoseal,Duraseal and Tachosil were comparable.Liqoseal showed no adherence to the arachnoid layer and was completely resorbed between 6 and 12 months postoperatively.In one animal with Liqoseal,an epidural fluid collection containing CSF could not be excluded.Conclusion:Liqoseal seems to be safe for intracranial use and is biodegradable.The safety and performance in humans needs to be further assessed in clinical trials.